Obio Technology Shanghai Corp Ltd (688238)

Currency in CNY
7.91
+1.16(+17.18%)
Delayed Data·
Earnings results expected in 5 days
688238 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.527.99
52 wk Range
5.018.82
Key Statistics
Bid/Ask
7.90 / 7.91
Prev. Close
6.75
Open
7.74
Day's Range
7.52-7.99
52 wk Range
5.01-8.82
Volume
30.2M
Average Volume (3m)
19.43M
1-Year Change
-18.9676%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688238 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
9.30
Upside
+17.57%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 9.30
(+17.57% Upside)

Earnings

Latest Release
Apr 27, 2026
EPS / Forecast
-0.08 / --
Revenue / Forecast
50.54M / --
EPS Revisions
Last 90 days

688238 Income Statement

Compare 688238 to Peers and Sector

Metrics to compare
688238
Peers
Sector
Relationship
P/E Ratio
−18.7x−4.6x−0.3x
PEG Ratio
−0.610.100.00
Price/Book
3.1x3.2x2.6x
Price / LTM Sales
16.1x7.6x3.1x
Upside (Analyst Target)
37.8%−0.7%48.5%
Fair Value Upside
Unlock−10.3%6.3%Unlock

Shanghai Obio Technology (Group) Corp., Ltd., a biotechnology company, engages in the provision of technical services for the field of regenerative medicine and anti-aging in China and internationally. The company offers customized plasmid design and viral vector packaging services; AAV serotypes and tissue-specific promoters to support scientific research; and research grade, NHP Grade, cGMP grade vector manufacturing process, for basic research, translational research and clinical trials. It also provides CDMO services encompassing process development, analytical methods, IND-enabling chemistry, manufacturing, and controls; and clinical and commercial manufacturing for viral vector, oncolytic virus, and cell therapy products, as well as engages in the production and sales of biological raw materials, biological agents, reagents, and other products. The company was formerly known as Obio Technology (Shanghai) Corp., Ltd. and change its name to Shanghai Obio Technology (Group) Corp., Ltd. in March 2026. The company was founded in 2013 and is headquartered in Shanghai, China.

Employees
715
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
8.34M1.32%61.22M
Other Institutional Investors
142.58M22.62%1.05B
Public Companies & Retail Investors
479.39M76.06%3.52B
Total
630.31M100.00%4.63B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Shanghai Zhangjiang Science&Technology Venture Capital Co., Ltd3.68%23,200,813170,294
Zhejiang Huarui Shengyin Venture Capital Co., Ltd.2.94%18,522,145135,953

FAQ

What Is the Obio Tech Shanghai (688238) Stock Price Today?

The Obio Tech Shanghai stock price today is 7.91 CNY.

What Stock Exchange Does Obio Tech Shanghai Trade On?

Obio Tech Shanghai is listed and trades on the Shanghai Stock Exchange.

What Is the Stock Symbol for Obio Tech Shanghai?

The stock symbol for Obio Tech Shanghai is "688238."

What Is the Obio Tech Shanghai Market Cap?

As of today, Obio Tech Shanghai market cap is 4.25B CNY.

What Is Obio Tech Shanghai's Earnings Per Share (TTM)?

The Obio Tech Shanghai EPS (TTM) is -0.36.

When Is the Next Obio Tech Shanghai Earnings Date?

Obio Tech Shanghai will release its next earnings report on Aug 25, 2026.

From a Technical Analysis Perspective, Is 688238 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Obio Tech Shanghai Stock Split?

Obio Tech Shanghai has split 1 times.

How Many Employees Does Obio Tech Shanghai Have?

Obio Tech Shanghai has 715 employees.

What is the current trading status of Obio Tech Shanghai (688238)?

As of Aug 20, 2026, Obio Tech Shanghai (688238) is trading at a price of 7.91 CNY, with a previous close of 6.75 CNY. The stock has fluctuated within a day range of 7.52 CNY to 7.99 CNY, while its 52-week range spans from 5.01 CNY to 8.82 CNY.

What Is Obio Tech Shanghai (688238) Price Target According to Analysts?

The average 12-month price target for Obio Tech Shanghai is 9.30 CNY, with a high estimate of 9.3 CNY and a low estimate of 9.3 CNY. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +17.57% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.